41![Oncogene, 6184–6193 & 2007 Nature Publishing Group All rights reserved $30.00 www.nature.com/onc ORIGINAL ARTICLE Oncogene, 6184–6193 & 2007 Nature Publishing Group All rights reserved $30.00 www.nature.com/onc ORIGINAL ARTICLE](https://www.pdfsearch.io/img/ead70267fe08e97d11f32f69f9c86198.jpg) | Add to Reading ListSource URL: www.nature.comLanguage: English - Date: 2007-09-13 04:56:44
|
---|
42![Hindawi Publishing Corporation Case Reports in Hematology Volume 2015, Article ID, 5 pages http://dx.doi.orgCase Report Hindawi Publishing Corporation Case Reports in Hematology Volume 2015, Article ID, 5 pages http://dx.doi.orgCase Report](https://www.pdfsearch.io/img/2e02b5540e6e70ad08330e9915ae9464.jpg) | Add to Reading ListSource URL: downloads.hindawi.comLanguage: English - Date: 2015-03-24 09:53:49
|
---|
43![Clinical Commissioning Policy: The use of Rituximab as a second line agent for the eradication of inhibitors in patients with Acquired Haemophilia Reference: NHS England xxx/x/x 1 Clinical Commissioning Policy: The use of Rituximab as a second line agent for the eradication of inhibitors in patients with Acquired Haemophilia Reference: NHS England xxx/x/x 1](https://www.pdfsearch.io/img/6942eaf1128834a495be3fe6d48d688a.jpg) | Add to Reading ListSource URL: www.engage.england.nhs.ukLanguage: English - Date: 2015-03-23 14:07:33
|
---|
44![Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients](https://www.pdfsearch.io/img/e137e9ca0714375e7c50be495f84baeb.jpg) | Add to Reading ListSource URL: mesoblast.comLanguage: English - Date: 2014-02-21 12:10:36
|
---|
45![TAG Mail 1st April 2015 TAG MEETINGS Nil TAG ACTIVITIES - Email discussions -- DTC approval of use of rituximab or adalimumab for sight-threatening uveitis TAG Mail 1st April 2015 TAG MEETINGS Nil TAG ACTIVITIES - Email discussions -- DTC approval of use of rituximab or adalimumab for sight-threatening uveitis](https://www.pdfsearch.io/img/26a1f7fb7735cf9e83d7d790083180b3.jpg) | Add to Reading ListSource URL: www.ciap.health.nsw.gov.auLanguage: English - Date: 2015-04-01 21:15:12
|
---|
46![Clinical Commissioning Policy: Rituximab for the treatment of relapsing steroid sensitive nephrotic syndrome Reference: NHS ENGLAND XXX/X/X 1 Clinical Commissioning Policy: Rituximab for the treatment of relapsing steroid sensitive nephrotic syndrome Reference: NHS ENGLAND XXX/X/X 1](https://www.pdfsearch.io/img/1fa8aa614647cd8fab8a5e8c2bfc06d9.jpg) | Add to Reading ListSource URL: www.engage.england.nhs.ukLanguage: English - Date: 2015-03-23 16:03:50
|
---|
47![[removed]efc-schedule.pdf [removed]efc-schedule.pdf](https://www.pdfsearch.io/img/4fb85900a4c3c213a1d2af4293825ff2.jpg) | Add to Reading ListSource URL: pbs.gov.auLanguage: English - Date: 2014-11-30 17:37:34
|
---|
48![Minutes of the SMC Meeting Minutes of the SMC Meeting](https://www.pdfsearch.io/img/ad7f4e9737db41a2eae26019c75968b9.jpg) | Add to Reading ListSource URL: www.scottishmedicines.org.ukLanguage: English |
---|
49![SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of](https://www.pdfsearch.io/img/5167e7bc0273048cae4b2050919c2f5e.jpg) | Add to Reading ListSource URL: www.scottishmedicines.org.ukLanguage: English |
---|
50![ALLG Safety and Data Monitoring Committee ALLG Safety and Data Monitoring Committee](https://www.pdfsearch.io/img/8c4216342fc77ee1d0f4ddc34e0aa596.jpg) | Add to Reading ListSource URL: www.allg.org.auLanguage: English - Date: 2014-05-29 08:24:27
|
---|